Sebi's CAS Review: A Nudge on Price Discovery
The recent news that Sebi plans to review the Computed Average Price (CAS) methodology for derivative contract settlement prices might seem like a niche technicality. It's about how the National Stock Exchange (NSE) calculates the closing price for futures and options, especially when there's low trading volume at market close. Essentially, they're looking for a more robust way to ensure that the final price reflects true market sentiment, preventing manipulation or mispricing in illiquid moments.
But here's why this matters to you, an investor looking at unlisted shares or pre-IPO opportunities: the core issue is price discovery. If even a highly liquid, regulated market like derivatives needs to refine its price calculation for fairness and accuracy, imagine the complexities in the unlisted space. That's where unlisted valuations become not just important, but absolutely critical.
Why Unlisted Valuations are a Different Beast
Public markets have a continuous price feed – millions of buyers and sellers interacting every second. That's your primary valuation mechanism. Unlisted shares don't have this. Their valuation is often a snapshot, a projection, or a negotiation.
Think of it this way: when you buy a share of Reliance Industries, you know its price down to two decimal places, updated instantly. When you look at a promising startup like say, a well-funded SaaS company aiming for an IPO in 2-3 years, its "price" isn't an hourly quote. It's a calculated value, often based on a mix of financial models, comparable transactions, and future growth prospects. The methodology, assumptions, and benchmarks used in this calculation are everything.
The Problem of Infrequent Trading
Just like Sebi is worried about low volume impacting derivative settlement prices, unlisted shares inherently suffer from infrequent trading. A block of shares might trade once a quarter, or even less often. The price from that last transaction might be outdated the moment new financial results come out, or a competitor raises fresh capital at a higher multiple. This makes relying solely on past trades a risky proposition for unlisted shares.
Key Methodologies for Unlisted Valuations
There isn't one magic formula for valuing unlisted companies. It's usually a blend, with different methods weighted based on the company's stage, sector, and profitability.
- Discounted Cash Flow (DCF): This is the gold standard for mature, predictable businesses. It projects future free cash flows and discounts them back to the present. The challenge? Making accurate long-term projections for a growth-stage unlisted company is tough. Small changes in assumptions (growth rate, terminal value, discount rate) can swing the valuation wildly.
- Comparable Company Analysis (CCA) / Multiples Method: This is often the most practical. You identify publicly traded companies (or recently acquired private ones) that are similar in business model, size, and growth stage. You then apply their valuation multiples (like EV/Revenue, P/E, EV/EBITDA) to your unlisted target's financials.
- The Catch: "Comparable" is subjective. Finding truly identical public companies for an innovative startup is rare. You often have to adjust for size, growth prospects, market leadership, and the "liquidity discount" for unlisted shares.
- Precedent Transactions: Looking at recent M&A deals or funding rounds for similar companies can give you a benchmark. What did a strategic buyer or a venture capital fund pay for a company like yours recently?
- The Catch: These transactions are often private, and the specific terms (synergies, control premiums) might not apply to a minority stake investment.
- Asset-Based Valuation: Less common for high-growth tech firms, but relevant for asset-heavy businesses (real estate, manufacturing). You value the company based on the fair market value of its underlying assets.
The "Liquidity Discount" and Control Premium
When valuing unlisted shares, two critical adjustments often come into play:
- Liquidity Discount: Shares in an unlisted company are inherently less liquid than public shares. You can't just sell them on an exchange anytime you want. This illiquidity typically warrants a discount, often in the range of 10-30% or even more, compared to what a similar company might fetch if it were publicly traded. The exact discount depends on factors like the company's stage, future IPO prospects, and shareholder agreements.
- Control Premium: If you're acquiring a controlling stake, you'd typically pay a premium over a minority stake. This is because control gives you the power to influence strategy, dividends, and future sale decisions. Most investors in unlisted shares, however, are buying minority stakes, so this is less relevant for the typical pre-IPO investor.
Why a Robust Valuation Process is Your Shield
Just as Sebi wants to ensure fairness in derivative pricing, you need to ensure fairness and accuracy in your unlisted investments. A robust valuation process helps you:
- Avoid Overpaying: The biggest risk in the unlisted space is getting caught in a hype cycle and buying shares at an unsustainable valuation.
- Set Realistic Expectations: A clear valuation helps you understand the potential upside and downside, and when to exit.
- Negotiate Better: If you understand the underlying value drivers, you can negotiate better entry prices.
- Benchmark Performance: How is the company performing against its valuation assumptions? Regular re-valuations are key.
For example, a late-stage fintech company might be valued at 20x its last twelve months' revenue in a private round. This might seem high, but if public market comparables for similar growth-stage fintechs are trading at 15x-25x revenue, and the company is growing at 80% year-on-year, the valuation might be justifiable, especially if an IPO is on the horizon. However, if growth slows to 30%, that 20x multiple becomes very difficult to sustain.
Sebi's Move, Your Opportunity
Sebi's review of the CAS methodology is a reminder that even in highly structured markets, price discovery is complex and requires constant scrutiny. For investors in the unlisted space, this complexity is magnified. It underscores the absolute necessity of rigorous due diligence and a deep understanding of valuation methodologies.
Don't just rely on the last transacted price or a founder's projection. Get specific. Ask for the detailed valuation report. Understand the assumptions. Challenge the comparables. This is where expertise truly pays off.
What to Look for in a Valuation Report:
- Clear Methodology: Which methods were used (DCF, CCA, Precedent)?
- Assumptions: What growth rates, discount rates, margins, and multiples were applied? Are they justified?
- Comparables: Are the chosen public/private companies truly comparable? Are adjustments made for size, stage, geography?
- Sensitivity Analysis: How does the valuation change if key assumptions (e.g., revenue growth, discount rate) vary?
- Liquidity Discount: Has an appropriate liquidity discount been applied for the unlisted nature of the shares?
The unlisted market offers phenomenal opportunities for wealth creation, but it demands a sharper analytical edge. Mastering the art and science of unlisted valuations is your primary tool in navigating this exciting, yet nuanced, landscape.
Frequently Asked Questions
What is the biggest risk with unlisted valuations?
The biggest risk is overpaying due to inaccurate or overly optimistic assumptions, or a lack of understanding of the illiquidity inherent in unlisted shares. Unlike public markets, there isn't a readily available, continuously updated market price to validate your entry point.
How often should an unlisted company be re-valued?
Ideally, a significant re-valuation should occur with every major funding round, significant change in business model, or material shift in market conditions. Many sophisticated investors will perform an internal re-valuation at least annually, or quarterly if the company is growing rapidly or approaching an IPO.
Can I use public company multiples directly for unlisted shares?
No, not directly. While public company multiples (like EV/Revenue or P/E) are a great starting point for comparable company analysis, you must apply adjustments. The most common adjustment is a "liquidity discount" to account for the inability to easily buy or sell unlisted shares compared to public ones. You might also adjust for size, growth stage, and market leadership.
Where can I get help with unlisted valuations?
For complex unlisted valuations, especially for significant investments, it's prudent to engage independent financial advisors or valuation experts. They have the models, data, and experience to provide an unbiased assessment, helping you make informed decisions.
Ready to explore unlisted opportunities with a clear understanding of valuation? Talk to an advisor at Neoma Capital today.
This is educational content, not investment advice. Investments in securities are subject to market risks.